share_log

Wells Fargo Maintains Equal-Weight on Alnylam Pharmaceuticals, Raises Price Target to $287

Benzinga ·  Mar 21 13:15

Wells Fargo analyst Tiago Fauth maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price target from $275 to $287.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 384
Write a comment